cropped-gtc_logo_grey_circle_2022

ASH 2022

New Orleans, Louisiana

Type:

Congress

Date (start):

December 10, 2022

Date (end):

December 13, 2022

Location:

Ernest N. Morial Convention Center

Booth#:

205

Admission Fee: 

Overview:

The 64th ASH Annual Meeting and Exposition is scheduled to take place December 10-13, 2022 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.

GTC is excited to be exhibiting at ASH! You can find GTC at booth # 205. We look forward to meeting with you at the show. 

Our team will be available to discuss our industry-leading Hematology Profile Plus assay which covers DNA, RNA and our new Liquid Trace test which is the first to offer comprehensive cfRNA analysis and reduces the interests for bone marrow biopsies.  

A few activities we’d like to highlight: 

GTC is hosting a happy hour on Sunday, December 12th from 5 PM at 8 PM at Calcisieu (next to Cochon). If you would like to attend, please RSVP to jowen@genomictestingcooperative.com 

GTC will also be presenting several posters. Here is a list of dates and times for the posters: 

DNA and RNA Profiles in Machine Learning Algorithm to Predict Which Patients with AML/MDS Will Respond to Venetoclax-Based Therapy 

Result Type: Paper 
Number: 2789 
Presenter: Maher Albitar 
Program: Oral and Poster Abstracts 
Session: 617. Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster II 
Time and Location: 
Sunday, December 11, 2022: 6:00 PM-8:00 PM 
Hall D (Ernest N. Morial Convention Center) 
Search Result: 
… (AI), Clinical Research, Diseases, Therapies, Myeloid Malignancies, Technology and Procedures, machine learning Sunday, December 11, 2022, 6:00 PM-8:00 PM Maher Albitar, MD1*, Andrew Ip, MD, MSc2, Andre H. Goy, MD, MS3*, Katherine Linder, MD4*, Jeffrey Justin Estella, BS, MS1*, Ahmad Charifa,  

Liquid Immunophenotyping and the Diagnosis of Lymphoid Neoplasms Using Cell-Free RNA 

Result Type: Paper 
Number: 3488 
Presenter: Maher Albitar 
Program: Oral and Poster Abstracts 
Session: 803. Emerging Tools, Techniques and Artificial Intelligence in Hematology: Poster II 
Time and Location: 
Sunday, December 11, 2022: 6:00 PM-8:00 PM 
Hall D (Ernest N. Morial Convention Center) 
Search Result: 
… Diseases, Lymphoid Malignancies, Technology and Procedures, Minimal Residual Disease , machine learning Sunday, December 11, 2022, 6:00 PM-8:00 PM Maher Albitar, MD1*, Hong Zhang, PhD1*, Andrew Ip, MD, MSc2, Jeffrey Justin Estella, BS, MS1*, Ahmad Charifa, MD1*, Wanlong Ma1*, Ipsa Sharma1*,  

Disparities in Somatic Mutations and Outcomes in Primary Central Nervous System Lymphoma Comparing Patients of Hispanic and Non-Hispanic Ethnicity 

Result Type: Paper 
Number: 1543 
Presenter: Haifaa Abdulhaq 
Program: Oral and Poster Abstracts 
Session: 621. Lymphomas: Translational—Molecular and Genetic: Poster I 
Time and Location: 
Saturday, December 10, 2022: 5:30 PM-7:30 PM 
Hall D (Ernest N. Morial Convention Center) 
Search Result: 
… Mahmood, MD2, Calvin Kuan Jung Chen, DO3*, Azra Borogovac, MD4, Matthew Wieduwilt, MD4*, Anand Annan5*, Yueqi Yan, PhD6* and Maher Albitar, MD7*1University of California, San Francisco, Fresno, CA2University of California, San Francisco-Fresno, Fresno, CA3Pathology Associates, Clovis, CA4Stephenson Cancer Center, University of  

Using Targeted Transcriptome and Machine Learning of Pre- and Post-Transplant Bone Marrow Samples to Predict Acute Gvhd (aGVHD) and Overall Survival after Allogeneic HSC Transplantation 

Result Type: Paper 
Number: 2076 
Presenter: Maher Albitar 
Program: Oral and Poster Abstracts 
Session: 722. Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I 
Time and Location: 
Saturday, December 10, 2022: 5:30 PM-7:30 PM 
Hall D (Ernest N. Morial Convention Center) 
Search Result: 
… Malignancies, CMML, Diseases, Lymphoid Malignancies, Myeloid Malignancies, Technology and Procedures, machine learning Saturday, December 10, 2022, 5:30 PM-7:30 PM Maher Albitar, MD1*, Hong Zhang, PhD1*, Andrew L. Pecora, MD2*, Andrew Ip, MD, MSc3, Andre H. Goy, MD, MS4*, Spiraggelos Antzoulatos1*, Wanlong